Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) shares fell to a low of $20.68 before closing at $21.58. Intraday shares traded counted 0.31 million, which was 71.91% higher than its 30-day average trading volume of 1.12M. OCDX’s previous close was $20.99 while the outstanding shares total 206.20M. The stock’s Relative Strength Index (RSI) is 64.14, with weekly volatility at 3.05% and ATR at 0.77. The OCDX stock’s 52-week price range has touched low of $15.14 and a $21.82 high. The stock traded higher over the last trading session, gaining 2.81% on 06/10/21.
Investors have identified the Diagnostics & Research company Ortho Clinical Diagnostics Holdings plc as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $5.03 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Ortho Clinical Diagnostics Holdings plc (OCDX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For OCDX, the company has in raw cash 153.8 million on their books with 139.4 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 919.8 million total, with 564.9 million as their total liabilities.
OCDX were able to record -23.3 million as free cash flow during the 09/01/2021 quarter of the year, this saw their quarterly net cash flow reduce by 20.3 million. In cash movements, the company had a total of -9.9 million as operating cash flow.
Potential earnings growth for Ortho Clinical Diagnostics Holdings plc (OCDX)
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 248.2 million trying to sell their products during the last quarter, with the result yielding a gross income of 258.6 million. This allows shareholders to hold on to 206.20M with the recently reported earning now reading -0.19 cents per share. This is a figure that compared to analyst’s prediction for their 09/01/2021 (0.25 cents a share).
Having a look at the company’s valuation, the company is expected to record 0.67 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on OCDX sounds very interesting.
Is the stock of OCDX attractive?
In the last 6 months, insiders have changed their ownership in shares of company stock by 0.60%.
11 out of 12 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on Ortho Clinical Diagnostics Holdings plc. 0 analysts has assigned a Sell rating on the OCDX stock. The 12-month mean consensus price target for the company’s shares has been set at $24.73.